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Original Article 
SIRT3 Protects Rotenone-induced Injury in SH-SY5Y 
Cells by Promoting Autophagy through the LKB1-
AMPK-mTOR Pathway 
 
Meng Zhang1, #, Yong-Ning Deng1, #, Jing-Yi Zhang1, Jie Liu1, Yan-Bo Li1, Hua Su2, Qiu-Min 
Qu1, * 
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2Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of 
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  [Received April 28, 2017; Revised May 5, 2017; Accepted May 17, 2017] 
 
ABSTRACT: SIRT3 is a class III histone deacetylase that modulates energy metabolism, genomic stability and 
stress resistance. It has been implicated as a potential therapeutic target in a variety of neurodegenerative 
diseases, including Parkinson’s disease (PD). Our previous study demonstrates that SIRT3 had a 
neuroprotective effect on a rotenone-induced PD cell model, however, the exact mechanism is unknown. In this 
study, we investigated the underlying mechanism. We established a SIRT3 stable overexpression cell line using 
lentivirus infection in SH-SY5Y cells. Then, a PD cell model was established using rotenone. Our data 
demonstrate that overexpression of SIRT3 increased the level of the autophagy markers LC3 II and Beclin 1. 
After addition of the autophagy inhibitor 3-MA, the protective effect of SIRT3 diminished: the cell viability 
decreased, while the apoptosis rate increased; α-synuclein accumulation enhanced; ROS production increased; 
antioxidants levels, including SOD and GSH, decreased; and MMP collapsed. These results reveal that SIRT3 
has neuroprotective effects on a PD cell model by up-regulating autophagy. Furthermore, SIRT3 overexpression 
also promoted LKB1 phosphorylation, followed by activation of AMPK and decreased phosphorylation of 
mTOR. These results suggest that the LKB1-AMPK-mTOR pathway has a role in induction of autophagy. 
Together, our findings indicate a novel mechanism by which SIRT3 protects a rotenone-induced PD cell model 
through the regulation of autophagy, which, in part, is mediated by activation of the LKB1-AMPK-mTOR 
pathway. 
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Parkinson’s disease (PD) is the second most common 
neurodegenerative disorder, affecting 1-3% of the 
population older than 50 years and more than 5 million 
people worldwide [1]. It is mainly characterized by a 
substantial loss of dopamine-containing neurons in the 
substantia nigra pars compacta. Previous studies have 
shown that accumularion of α-synuclein, oxidative stress 
and mitochondrial dysfunction are involved in the 
pathogenesis of PD[2]. These factors interact with and 
intensify each other and ultimately lead to neuronal death. 
Therefore, an ideal therapy should be able to address these 
problems simultaneously [3]. 
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        Autophagy, or cellular self-digestion, is a cellular 
pathway involved in protein and organelle degradation, 
with an astonishing number of connections to human 
disease and physiology. There are various types of 
autophagy, including macro- and microautophagy, as well 
as chaperone-mediated autophagy (CMA), and they differ 
in mechanisms and functions. More and more evidence 
has shown that autophagy plays a protective role in 
neurodegenerative diseases [4-6]. Evidence shows that α-
synuclein could be degraded both by macroautophagy and 
CMA [7, 8]. In agreement with this pivotal role of 
autophagy in α-synuclein clearance, overexpression of 
Beclin 1 reduces α-synuclein aggregation and neuronal 
pathology [9]. In addition, autophagy plays important 
roles in preserving mitochondria function and oxidative 
stress control. Mitochondrial dynamics are crucial in 
preventing potential damage generated by ROS. Damaged 
mitochondrial degradation by autophagy is called 
mitophagy. Thus, mitophagy is of great importance in 
blocking the production of ROS [10]. Autophagy 
enhancement acts as an adaptive metabolic response to 
prevent increased levels of reactive oxygen species and 
cell death [11]. It was reported that autophagy-related 
gene knockout mice accumulate ROS and dysfunctional 
mitochondria with altered morphology [12]. 
Correspondingly, ROS-induced mitochondrial damage 
may also be an important upstream activator of mitophagy 
[13]. Taken together, disruption of autophagy may cause 
accumulation of α-synuclein aggregates in neurons[14], 
slow the degradation of damaged mitochondria and thus, 
increase the level of oxidative stress [15]. Conversely, up-
regulation of autophagy may alleviate these pathologies 
that are linked to PD. 
        Sirtuins are conserved proteins with an NAD+-
dependent deacetylase and mono-ADP-ribosyltransferase 
activity (class III histone deacetylases), including seven 
different proteins (SIRT1-SIRT7) in mammals. SIRT3 is 
a mitochondrial deacetylase that is enriched in highly 
metabolic tissues, such as the liver, heart, brain and brown 
adipose tissue. SIRT3 has been reported to regulate almost 
every aspect of the mitochondria [16]. Our previous study 
demonstrated that SIRT3 protects neuronal cells from 
rotenone-induced toxicity, reduces α-synuclein 
aggregation, and ameliorates oxidative stress [17]. 
However, further studies are necessary to determine the 
mechanism of these protective effects. SIRT3 also acts as 
an upstream or direct regulator in promoting autophagy 
[18-22]. SIRT3 has been shown to activate the LKB1-
AMPK signaling pathway in a cardiac hypertrophy mouse 
model [23]. AMPK may act as an activator to promote 
autophagy via mTOR or through an interaction with 
ULK1 [24]. To our knowledge, no reports about SIRT3, 
PD and autophagy have been put forward so far.  
Jang et al. established an in vitro PD model by 
applying rotenone on SH-SY5Y cells and found various 
neuroprotective substances with autophagic modulation 
properties, such as erythropoietin [25] and 1,25-
Dyhydroxyvitamin D(3) [26]. In this study, the same in 
vitro PD model was used. We hypothesized that the 
neuroprotective effect of SIRT3 may be through the 
induction of autophagy via the LKB1-AMPK-mTOR 
signaling pathway. 
 
MATERIALS AND METHODS 
 
Materials  
 
The rotenone, puromycin, 3-Methyladenine (3-MA), 
Dorsomorphin, 2’, 7’-dichlorodihydrofluorescein 
diacetate (DCFH-DA), 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) and retinoic acid 
(RA) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). The Bafilomycin A1 was obtained from Aladdin 
(Shanghai, China). The PE Annexin V Apoptosis 
Detection Kit was purchased from the Becton-Dickinson 
Company (Franklin lakes, NJ, USA). The GSH Assay Kit 
and SOD Assay Kit were provided by the Nan-Jing 
Jiancheng Biocompany (Nanjing, Jiangsu, China). The 
MMP Assay Kit with JC-1 was from Beyotime (Haimen, 
Jiangsu, China). The antibodies were purchased from the 
following companies: alpha-synuclein from the Becton-
Dickinson Company (Franklin lakes, NJ, USA); LKB1, p-
LKB1 (Ser428), AMPK, p-AMPK (Thr172), and Beclin 1 
from Cell Signaling Technology (Danvers, MA, USA); 
LC3 from Sigma-Aldrich (St. Louis, MO, USA); mTOR 
(S2442) and p-mTOR (S2448) from Bioworld (St. Louis 
Park, MN, USA); β-actin from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA); goat anti-mouse IgG secondary 
antibody and goat anti-rabbit IgG secondary antibody 
(both peroxidase conjugated) were purchased from 
Signalway Antibody (College Park. MD, USA). A goat 
anti-mouse IgG (Cy3-conjugated) was purchased from 
Zhuangzhi Biotechnology (Xi’an, China). 
 
Cell culture and drug treatment 
 
The human neuroblastoma cell line, SH-SY5Y, obtained 
from American type culture collection (Manassas, VA, 
USA) was cultured in DMEM/F12 medium (Hyclone, 
Logan, UT), supplemented with heat-inactivated 10% 
fetal bovine serum (Biological Industries, Kibbutz Beit 
Haemek, Israel), in a humidified atmosphere containing 5% 
CO2 at 37°C.  
        To induce differentiation, the SH-SY5Y cells were 
treated with with RA (10 μM) in 1% FBS medium in the 
dark for 5 days. The short processes in the undifferentiated 
state developed into long neurites in SH-SY5Y cells, 
reflecting a neuronal phenotype (Fig.1).  
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        The 3-MA was dissolved in sterile PBS with heating. 
The rotenone, Dorsomorphin and Bafilomycin A1 were 
dissolved in DMSO (final concentration of DMSO was 
0.01%). The 3-MA (5mM) was added 1h prior to rotenone 
treatment. Rotenone (60μM) was used to incubate with 
cells for 24h to induce cell damage. Dorsomorphin (40μM) 
and Bafilomycin A1 (100nM) took 100min to take effect 
on the cells. To investigate whether SIRT3 could induce 
autophagy or not, 6 groups were established: WT-group, 
vehicle-group, SIRT3-group, WT+ Bafilomycin A1-
group, vehicle+ Bafilomycin A1-group, and SIRT3+ 
Bafilomycin A1-group. To clarify whether autophagy is 
involved in the neuroprotective effect of SIRT3, the cells 
were divided into 9 groups: WT-group (SH-SY5Y cells 
without lentivirus infection), WT+Rot-group, WT+3-
MA-group, Vehicle-group (lentivirus vector infection 
without targeting genes), Vehicle+Rot-group, Vehicle+3-
MA-group, SIRT3-group (lentivirus infection with SIRT3 
overexpression genes), SIRT3+Rot-group, and 
SIRT3+Rot+3-MA-group. To examine the LKB1-
AMPK-mTOR pathway, 6 groups were generated: WT-
group, vehicle-group, SIRT3-group, WT+ Dorsomorphin-
group, vehicle+ Dorsomorphin-group, and SIRT3+ 
Dorsomorphin-group. 
 
 
 
Figure 1. Differentiation of SH-SY5Y cells. (A) Undifferentiated SH-SY5Y cells cultured in 10% 
complete medium for 5 days. (B) Differentiated SH-SY5Y cells cultured in 1% cultural medium with 
RA (10 μM) for 5 days. 
Lentiviral infection of SH-SY5Y cells  
 
To overexpress or silence SIRT3, LV-SIRT3 (6848-2) or 
LV-SIRT3i lentiviral vectors were produced, respectively, 
with Puromycin-resistance genes (Shanghai Genechem 
Co. Ltd.). For the overexpression of SIRT3, primers 
specific to the human SIRT3 gene were synthesized, and 
the sequences were as follows: (a) SIRT3-P1: 
CCAACTTTGTGCCAACCGGTCGCCACCATGGCGT
TCTGGGGTTGG; (b) SIRT3-P2: AATGCCAACTCTG 
AGCTTTTTGTCTGGTCCATCAAGC. Four shRNAs 
with different target sequences are listed as follows: 
ACCTGCACAGTCTGCCAA (SIRT3-RNAi-1), GGCT 
CTACACGCAGAACAT (SIRT3-RNAi-2), CAACGT 
CACTCACTACTTT (SIRT3-RNAi-3), and GGGTGCT 
TCAAGTGTTGTT (SIRT3-RNAi-4). Both the SIRT3 
overexpression and silencing genes were designed to 
carry puromycin-resistance genes and produced using the 
Lentivector Expression System (Shanghai Genechem Co. 
Ltd.). The SH-SY5Y cells were plated into 96-well culture 
plates (5000/well) and infected with lentivirus (MOI=10) 
on the day following when the cells reached 80% 
confluence. Stable singal clones were selected following 
4-8 weeks of puromycin treatment (2μg/μL). SIRT3 
expression in the stably infected clones was assessed 
using western blot analysis. One of the four shRNAs was 
selected by western blotting with the highest silencing 
efficiency[27]. 
 
Cell viability assessment measured by the MTT 
assay 
 
The SH-SY5Y cells were seeded into 96-well culture 
plates at a density of 8000/well in 0.2ml of culture 
medium. After being treated with different testing agents, 
the cells were incubated together with 5 mg/ml MTT for 
4 h at 37°C. Then, the medium in each well was carefully 
aspirated, followed by addition of 150μl of DMSO in each 
well. The crystals were dissolved in DMSO and quantified 
by measuring the absorbance at 490nm using an 
automated micro-plate reader (BIO-TEK, VT, USA). 
 
Apoptosis analysis 
 
Apoptosis of the cells was detected using the PE Annexin 
V Apoptosis Detection Kit (BD Pharmingen). After being 
treated with different testing agents, the cells were 
collected and washed twice with cold phosphate buffered 
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saline (PBS), centrifuged at 1200 rpm for 5 minutes, and 
resuspended in 1X binding buffer at a concentration of 
1×106 cells/ml. One hundred microliters of the above 
solution (1×105 cells) were transferred to a 10ml 
centrifuge tube and 5 μl PE Annexin V and 5 μl 7-AAD 
was added to the solution. The cells were gently vortexed 
and incubated for 15 minutes at room temperature in the 
dark, and then, 400μl of binding buffer was added to each 
tube. Apoptosis was measured by a FACScan flow 
cytometer (Becton Dickinson). The PE Annexin V -
positive, 7-AAD-negative cells were scored as early 
apoptotic cells, while both positive for PE Annexin V- and 
7-AAD-positive cells were considered to be late apoptotic 
cells.  
 
Detection of SOD, GSH 
 
SOD and GSH were detected using the corresponding kits. 
After being treated with the indicated drugs, the cells were 
harvested, suspended in PBS and then fragmented with 
ultrasonic liquid processors (Sonics). The SOD and GSH 
in the suspension were analyzed according to the 
manufacturer’s instructions. For the detection of SOD and 
GSH, 450 nm and 405 nm were used, respectively, using 
an automated microplate reader (BioTek). 
 
Detection of ROS and MMP by Flow Cytometer 
 
The ROS was detected using DCFH-DA, and MMP was 
with the assay kit. After various treatments of each group, 
the cells were harvested with trypsin, then suspended in 
PBS, and immediately stained with DCFH-DA or JC-1 
according to the manufacturer’s instructions. Then, the 
samples were analyzed with a flow cytometer (FACScan 
flow cytometer, Becton Dickinson). 
 
Immunofluorescence staining 
 
The SH-SY5Y cells were seeded on cover slips in a 24-
well plate. After being treated with the indicated drugs, 
the cells on the cover slips were fixed in 4% 
paraformaldehyde for 30 min, washed with PBS, 
permeabilized with 0.1% Triton-X100, blocked in 5% 
BSA in PBS, and incubated with anti-alpha-synuclein 
(1:100) at 4°C overnight. Then, the cells were washed 
with PBS and incubated with Cy3-conjugated goat-anti-
mouse IgG (1:100) at 37°C for 1 h, followed by staining 
with DAPI. The slides were subsequently mounted using 
glycerin and were observed under a confocal microscope 
(Olympus, Tokyo, Japan). The images were analyzed 
using ImageJ.  
 
 
 
Immunoblotting 
 
The SH-SY5Y cells were washed twice with ice-cold PBS 
and then lysed in RIPA lysis buffer containing a protease 
inhibitor cocktail (Roche, Munich, Germany) and a 
phosphorylase inhibitor cocktail (Roche, Munich, 
Germany). After centrifugation at 4°C, the extracted 
proteins were quantified by the BCA kit (Beyotime, 
Jiangsu, China), and 100μg of protein from each group 
was loaded onto a 12% SDS-PAGE gel. After 
electrophoresis, the proteins were transferred onto PVDF 
membranes. Non-specific protein binding was blocked 
with 5% non-fat milk in PBS for 2 h at room temperature. 
The membranes were incubated with anti-LC3 (1:1,000), 
anti-Beclin 1 (1:800), anti-LKB 1 (1:600), anti-p-LKB1 
(1:600), anti-AMPK (1:600), anti-p-AMPK (1:600), anti-
mTOR (1:500), anti-p-mTOR (1:500),anti-α-synuclein 
(1:250) and anti-β-actin (1:1,0000) overnight at 4°C. After 
washing with PBST, the membranes were incubated with 
secondary antibodies conjugated with HRP at room 
temperature for 1 h. The signal was detected using an 
enhanced chemiluminescence detection kit (Millipore, 
USA). The immunoreactive bands of proteins were 
scanned with chemidoc XRS (Bio-Rad), and the digitized 
data were quantified as area and percentage of each band 
using ImageJ software. 
 
Electron microscopy 
 
To confirm the autophagosome structures of autophagy, 
WT, Vehicle and SIRT3-overexpression SH-SY5Y cells 
were fixed with 2% glutaraldehyde for 2 h, washed with 
PBS and then post-fixed with 1% OsO4 for 1.5 h at 48°C. 
The samples were then washed and dehydrated with 
graded alcohol. After dehydration, the samples were 
infiltrated and embedded in 618 epoxy resin. Ultrathin 
sections were cut, stained with uranyl acetate and lead 
citrate and then examined under the transmission electron 
microscope H7650 (Hitachi, Tokyo, Japan). 
 
Statistical analysis 
 
Significant differences among groups were determined 
with one-way analysis of variance (ANOVA) followed by 
a Tukey test using statistical software SPSS version 18.0. 
The data are presented as the mean ± SEM using 
Graphpad Prism (Graph Pad, San Diego, CA). The P 
values less than 0.05 were considered significant. All 
results were confirmed from a minimum of three 
independent experiments.  
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Figure 2. SIRT3 increases autophagy in human neuroblastoma SH-SY5Y cells. Lysates from cells untreated, 
or treated    with SIRT3-NC or SIRT3i-NC (non-targeting lentivirus), LV-SIRT3 (Lentivirus with a SIRT3 
overexpression gene) or LV-SIRT3i (Lentivirus with a SIRT3 silencing gene) were prepared and analyzed by 
western blotting. (A) SIRT3 overexpression and silencing using lentiviruses were identified by SIRT3 
immunoblotting with an antibody against SIRT3. Autophagy induction by SIRT3 was determined by the LC3II and 
Beclin1 protein levels with an antibody against LC3B and Beclin 1. β-actin is used as a loading control. Mean ± 
SEM, n=3. Bar graphs show the quantification of the relative levels of SIRT3 (B), LC3II (C) and Beclin 1 (F). (D) 
SH-SY5Y cells with or without SIRT3 overexpression were treated with 100 nM Bafilomycin A1 for 100 min. Cell 
lysates were prepared and analyzed by western blotting. (E) Bar graphs show the quantification of LC3II level ratios 
between WT+BA and WT, Vehicle+BA and Vehicle, SIRT3+BA and SIRT3 groups. β-actin is used as a loading 
control. Mean ± SEM, n=3. (G) Ultrastructural SH-SY5Y cells in WT, Vehicle (NT-lentivirus) and LV-SIRT3 
(SIRT3+) groups. Black arrows indicate mitochondria. White arrows show different stages of autophagic vascuoles
： * represents an early autophagic vacuole (AVi); ** represents a degradative autophagic vacuole (AVd). An AVi 
can be identified by its contents (morphologically intact cytoplasm). The AVd contains partially degraded contents. 
Scale bars, 500 nm. 
 
RESULTS 
 
SIRT3 up-regulates autophagy in the SH-SY5Y cell line 
 
Upon differentiation, SH-SY5Y cells possess more 
biochemical, ultrastructural, morphological and 
electrophysiological similarity to neurons, resulting in a 
more ideal PD cell model. Thus, the SH-SY5Y cells used 
in each experiment were differentiated cells. After 
performing lentiviral infection, we performed western 
blotting analysis to test the infection efficiency. SIRT3 
expression increased significantly in the LV-SIRT3 group 
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and decreased substantially in LV-SIRT3i cells (Fig. 2A, 
2B). Immunoblotting for the most widely monitored 
autophagy-related protein, Atg8/LC3, indicated a 
significant increase of LC3II expression in the SIRT3 
overexpression-group compared with the Vehicle-group 
and a remarkable decrease in the LV-SIRT3i group (Fig. 
2A, 2C). To test whether SIRT3 increased LC3II 
expression by accelerating autophagy levels or by 
disrupting lysosomal degradation, we next delivered 
Bafilomycin A1 (100 nM, 100 min) to cells, and 
determined LC3II expression levels again. The LC3II 
levels in the WT, Vehicle and SIRT3 groups all increased 
dramatically after Bafilomycin A1 treatment, with the 
SIRT3+Bafilomycin A1-group displaying the greatest 
increase (Fig. 2D, 2E). Beclin 1 is vital in signaling the 
onset of autophagy. We found that Beclin 1 expression in 
the SIRT3 group increased significantly compared with 
the Vehicle group (Fig. 2A, 2F). The autophagosome, 
which is responsible for the sequestration of cytoplasm for 
degradation, is the morphological hallmark of autophagy. 
Thus, transmission electron microscopy was next used to 
examine the structure of the autophagosomes in SIRT3-
group cells compared with the Vehicle controls (Fig. 2G). 
The SIRT3 overexpression group had more formation of 
autophagosomes, which are structured with double-
membranes, than the Vehicle cells and WT cells. In 
conclusion, these data confirm the upregulation of 
autophagy by SIRT3 overexpression in the SH-SY5Y cell 
line. 
 
 
 
 
 
 
Figure 3. SIRT3 prevents rotenone-induced cell death in human neuroblastoma SH-SY5Y cells by upregulating autophagy. 
The SH-SY5Y cells with or without SIRT3 overexpression cultured in non-serum growth medium were treated with 60 μM rotenone 
for 24 h. Five millimolar 3-MA was added 1 h before rotenone. (A) Then, the treated cells were subjected to the MTT assay. Bar 
graph shows the quantification of cell viability determined by MTT assay in WT, WT+Rot, WT+3-MA, Vehicle, Vehicle+Rot, 
Vehicle+3-MA, SIRT3+, SIRT3+Rot, and SIRT3+Rot+3-MA groups. Mean ± SEM, n=3. #: P＜0.001 vs. Vehicle+Rotenone. After 
treatment as described above, cells were harvested, stained with 7-AAD (Y-axis) and PE-Annexin V (X-axis). Scatter diagram (B) 
and bar graph (C) show the flow cytometric analysis of staining from WT, WT+Rot, WT+3-MA, Vehicle, Vehicle+Rot, Vehicle+3-
MA, SIRT3+, SIRT3+Rot, and SIRT3+Rot+3-MA groups. The apoptotic rate= [AnnexinV-PE(+)7-AAD(-)cells + AnnexinV-
PE(+)7-AAD(+)cells]/total cells×100%. Mean ± SEM, n=3. Rot=Rotenone. δ: P＜0.001 vs. Vehicle+Rotenone.  
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SIRT3 protects SH-SY5Y cells from rotenone toxicity 
through up-regulating autophagy 
 
The addition of rotenone (60 μM, 24h) to the cell culture 
medium reduced the cell viability to approximately 50% 
in the WT+Rotenone-group and the Vehicle+Rotenone-
group, while treatment with rotenone on SIRT3+ cells 
caused the cell viability to decrease approximately 30%, 
indicating that SIRT3 overexpression preserved cell 
viability (Fig.3A). However, 3-MA could dramatically 
ameliorate the protective effect of SIRT3 on rotenone-
induced cell damage (Fig. 3A). After the cell viability was 
measured by the MTT assay, we next quantified the 
apoptosis rate of each group, and obtained similar results, 
where SIRT3 protects SH-SY5Y cells from apoptosis 
after rotenone treatment, and the protective effect of 
SIRT3 was again abolished by 3-MA (Fig. 3B, 3C). These 
findings suggest the involvement of autophagy in the 
neuroprotectiive effects of SIRT3 on the PD cell model. 
 
 
 
 
 
 
 
 
 
Figure 4. SIRT3 enhances the clearance of α-synuclein by upregulating autophagy. (A) SH-SY5Y cells with or without SIRT3 
overexpression cultured in non-serum growth medium were treated with 60μM rotenone for 24h. Five millimolar 3-MA was added 
1h before rotenone. The cells were immunostained for α-synuclein (red). DAPI staining was used to mark the position of the 
nuclei. Scale bars=50 μm. (B) A bar graph shows the quantification of mean fluorescence intensity of α-synuclein in each group. 
Mean ± SEM, n=3. δ: P＜0.001 vs. Vehicle+Rotenone. (C) The cells were treated in the same way as mentioned in A, and cell 
lysates were prepared and analyzed by western blotting using antibodies against α-synuclein. LC3 and Beclin 1 immunoblotting 
were performed to test the autophagic level under rotenone or 3-MA treatment. (D, E, F) Bar graphs show the quantification of 
the relative level of α-synuclein, LC3II and Beclin1 in each group. β-actin is used as a loading control. Mean ± SEM, n=3. #: P＜
0.001 vs. Vehicle+Rotenone. &: P＜0.01 vs. WT. σ: P＜0.001 vs. Vehicle. $: P＜0.001 vs. SIRT3.  
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Figure 5. SIRT3 upregulates intracellular SOD and GSH levels, prevents rotenone-induced ROS 
generation and MMP collapse in SH-SY5Y cells by upregulating autophagy. The SH-SY5Y cells 
with or without SIRT3 overexpression cultured in serum-free growth medium were treated with 60μM 
rotenone for 24 h. Five millimolar 3-MA was added 1h before rotenone. The cells were harvested and 
stained with DCFH-DA. (A) ROS levels were measured by a fluorescence-activated cell sorter. (B) Bar 
graph shows the quantification of ROS levels. Mean ± SEM, n=3. δ: P＜0.001 vs. Vehicle+Rotenone. 
The cells were collected for quantification of intracellular SOD (C), GSH (D) using the corresponding 
detecting kits. Mean ± SEM, n=3. #: P＜0.05 vs. Vehicle+Rotenone. δ: P＜0.001 vs. Vehicle+Rotenone. 
(E) MMP was measured by JC-1 aggregates/monomer using a flow cytometer. (F)  The bar graph shows 
the quantification of JC-1 aggregates/monomer levels in each group. Mean ± SEM, n=3. σ: P＜0.001 vs. 
Vehicle+Rotenone.  
 
Zhang, M. et al                                                                                             SIRT3 protects PD through autophagy 
Aging and Disease • Volume 9, Number 2, April 2018                                                                              281 
 
 
 
Figure 6. SIRT3 induces autophagy through the LKB1-AMPK-mTOR pathway. (A) 
The SH-SY5Y cells with or without SIRT3 overexpression were treated with 40 μM 
Dorsomorphin or control for 100 min. The cell lysates were analyzed by western blotting 
with the indicated antibodies. Data show the quantification of the p-LKB1/LKB1 ratio 
(B), p-AMPK/AMPK ratio (C), p-mTOR/mTOR levels (D) and LC3II (E). β-actin is 
used as a loading control. #: P＜0.001 vs. WT, $: P＜0.001 vs. Vehicle, &: P＜0.001 vs. 
SIRT3+. Mean ± SEM, n=3. 
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SIRT3 enhances clearance of α-synuclein by up-
regulating autophagy 
 
Given that α-synuclein accumulation is one of the 
pathologies of PD, we examined the relationship between  
SIRT3 and α-synuclein. Immunofluorescence staining 
showed that after 24 h incubation with cells, rotenone 
notably increased α-synuclein expression in the Vehicle 
cells, while α-synuclein levels were compromised in 
SIRT3-overexpression cells after rotenone treatment. The 
addition of 3-MA abolished this amelioration effect of 
SIRT3, and the α-synuclein positive fluorescence 
intensity increased distinctly in the SIRT3+Rotenone+3-
MA-group compared with the SIRT3+Rotenone-group 
(Fig. 4A, 4B). After the quantification at cellular level 
using fluorescence staining, we performed western blot 
analysis to confirm the SIRT3 and 3-MA effect on 
synuclein expression. α-synuclein levels almost tripled in 
the WT and Vehicle cells after rotenone treatment, while 
in the SIRT3 cells, its expression showed almost no 
change following rotenone treatment. Again, after 
addition of 3-MA, the effect of SIRT3 was blocked (Fig. 
4C, 4D). Western blot analyses for LC3II and Beclin 1 
were performed to test the autophagic levels after 
rotenone and 3-MA treatment. LC3II expression 
decreased significantly in the WT, Vehicle and SIRT3 
groups following rotenone and 3-MA treatment. Beclin1 
showed a significant decrease in SIRT3 cells after 
rotenone and 3-MA addition (Fig. 4C, 4E, 4F). These 
results thus demonstrated the involvement of autophagy 
in the SIRT3-mediated clearance of α-synuclein after 
rotenone treatment.  
 
SIRT3 attenuates rotenone-induced oxidative stress and 
mitochondrial dysfunction by upregulating autophagy  
 
Oxidative stress has been implicated in the propagation of 
neuronal dysfunction in multiple neurodegenerative 
diseases. Given that SIRT3 reduces the cell apoptosis 
percentage and increases cell viability after rotenone 
treatment, we next tested its effect on oxidative stress, 
with ROS expression indicating the oxidants level and 
SOD and GSH production representing the antioxidants 
level. After inhibition of autophagy using 3-MA (5 mM, 
1h), the protective effect of SIRT3 against oxidative stress 
diminished when comparing the SIRT3+Rotenone+3-
MA-group with the SIRT3+Rotenoe-group: ROS 
generation was enhanced (Fig. 5A, 5B) and intracellular 
SOD (Fig. 5C) and GSH levels (Fig. 5D) decreased. MMP 
was used to evaluate the degree of mitochondrial 
dysfunction. Flow cytometry results showed that there 
was a significant MMP reduction in the 
SIRT3+Rotenone+3-MA-group compared with the 
SIRT3+Rotenone-group. These results again 
demonstrated the involvement of autophagy in the 
neuroprotective effects of SIRT3, which attenuates 
rotenone-induced oxidative stress and mitochondrial 
dysfunction. 
 
SIRT3 upregulates autophagy through the LKB1-
AMPK-mTOR pathway 
 
AMPK is a positive regulator of autophagy via mTOR or 
ULK1[28]. We therefore focused our attention on the 
involvement of the AMPK signaling pathway in SIRT3-
mediated autophagy activation in SH-SY5Y cells. The 
results showed that AMPK activation (phosphorylation) 
was notably increased in SIRT3+ cells (Fig. 6A, 6C). The 
activity of AMPK is known to be regulated by an 
upstream kinase, LKB1. We therefore examined LKB1 
phosphorylation, and found that, similar to AMPK, LKB1 
phosphorylation was also significantly enhanced in 
SIRT3+ cells (Fig. 6A, 6B), and thus suggesting that 
SIRT3 had the capacity to upregulate the activity of LKB1 
and AMPK. Additionally, mTOR phosphorylation was 
reduced (Fig. 6A, 6D) and LC3Ⅱwas remarkably 
increased (Fig. 6A, 6E) in SIRT3+ cells compared with 
Vehicle cells. Thus, we extended our hypothesis that 
SIRT3 may induce autophagic level acceleration through 
the LKB1-AMPK-mTOR signaling pathway.  
Then, we used an AMPK inhibitor to continue to 
clarify the relationship between the LKB1-AMPK-mTOR 
signaling pathway and autophagy induction. 
Dorsomorphin, an AMPK inhibitor, can act as a reversible 
and ATP-competitive inhibitor of AMPK [29] and was 
used here. After delivery of Dorsomorphin (40 μM, 100 
min), AMPK phosphorylation reduced in WT, Vehicle and 
SIRT3 cells (Fig. 6A, 6C). At the same time, mTOR 
phosphorylation increased significantly in the SIRT3+ 
group (Fig. 6A, 6D). We also observed a significant 
decrease in LC3II expression after Dorsomorphin 
treatment in SIRT3+ cells (Fig. 6A, 6E). 
 
DISCUSSION 
 
In this study, we report that SIRT3 protects rotenone-
induced SH-SY5Y cell damage by upregulating 
autophagy, where it increases cell viability and decreases 
cell apoptosis, attenuates the accumulation of α-synuclein, 
increases intracellular SOD and GSH levels, ameliorates 
rotenone-induced ROS generation, and preserves MMP 
reduction in SH-SY5Y cells. These effects could be 
blocked upon the inhibition of autophagy. We also 
demonstrated that the modulation of autophagy by SIRT3 
is through the activation of the LKB1-AMPK-mTOR 
signaling pathway (Fig. 7).  
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Figure 7. A schematic model for SIRT3-induced autophagy and its underlying mechanism in SH-SY5Y cells following 
rotenone treatment. SIRT3 overexpression leads to an acceleration of LKB1 activation (phosphorylation) and downstream AMPK 
activation, thus decreasing mTOR phosphorylation and initiating an autophagic response. In a rotenone-induced Parkinson cell 
model, there is enhanced α-synuclein aggregation, accelerated oxidative stress and increased mitochondria dysfunction. With SIRT3 
overexpression and induced autophagic levels, these injuries are ameliorated. Blocking autophagy using 3-MA abolished the 
protective effect. Our results suggest that SIRT3 protects cells from rotenone by generating autophagy. The LKB1-AMPK-mTOR 
pathway is involved in the generation.   
An important finding reported here is the ability of 
SIRT3 to induce autophagy activity. Autophagy, which is 
the degradation of cytosolic components in lysosomes, 
has been recognized for more than five decades. A large 
number of studies have indicated that autophagy plays an 
important neuroprotective role in neurodegenerative 
diseases, including PD [4, 30, 31]. The role of SIRT3 in 
autophagy induction in SH-SY5Y cells has not been 
assessed before: however, previous studies have shown 
that autophagy can be induced in SH-SY5Y cells by other 
members of the sirtuin family, SIRT1 and SIRT2 [32-34]. 
We found that SIRT3 induces Beclin 1 expression and 
increases LC3II levels. Bafilomycin A1, an 
autophagosome-lysosome fusion inhibitor, was used to 
confirm this result. In addition, after SIRT3 silencing, 
autophagy levels decreased significantly. Together with 
the electron microscopy images, these data strongly 
suggest that SIRT3 could upregulate autophagy levels in 
SH-SY5Y cells. Another important finding reported here 
is the involvement of autophagy in the neuroprotective 
effects of SIRT3 through the MTT assay and apoptosis 
analysis. It should be noted that although in PD, 
autophagy plays beneficial effects on the disease’s 
progression, autophagy can exert both beneficial and 
aggravating effects on different diseases. Autophagy 
seemed to have a dual role, which not only could be 
cytoprotective but also could lead to cell death. This 
paradoxical role of autophagy always depends on the time 
and the extent of the induction of autophagy[35]. 
        Widespread accumulation of the α-synuclein protein 
in the form of Lewy bodies and Lewy neuritis is a 
neuropathological hallmark of PD [1]. The autophagy 
pathway was reported to be relevant to α-synuclein 
clearance [8]. Autophagy-lysosome pathway (ALP) 
inhibition significantly potentiates the toxicity of 
aggregated α-synuclein species in mice and cell 
models[36]. The conditional knock-out of the autophagy-
related gene Atg7 leads to the accumulation of α-
synuclein [37]. The cytoplasmic acetylation of α-
synuclein is implicated in the neuroprotection against PD 
[38]. Among these mitochondrial deacetylase sirtuins, 
SIRT3 plays an important role[39]. In our study, we found 
that SIRT3 diminished α-synuclein aggregation via the 
upregulation of autophagy. In accord with the previous 
report that 3-MA can suppress proteolysis independently 
of autophagy [40], we also observed an increase trend of 
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synuclein expression following 3-MA treatment both in 
WT and Vehicle cells.  
        Cumulative oxidative stress has been known to be a 
key factor in the acceleration of the aging process and the 
development of neurodegenerative disorders [41]. Defects 
in mitochondrial dynamics, and the generation and 
presence of ROS in many cases are associated with 
neurodegenerative diseases, such as PD[42]. Mitophagy, 
known as a selective form of autophagy, specifically 
targets damaged or superfluous mitochondria for 
autophagic degradation and has been repeatedly shown to 
take part in the maintenance of a healthy mitochondrial 
population. Evidence has shown that SIRT3 could 
promote oxidative stress resistance by deacetylating 
lysine residues on SOD2 [43]. SIRT3 is also an essential 
player in enhancing the mitochondrial glutathione 
antioxidant defense system during caloric restriction 
(CR)[44]. We found that SIRT3 blocked rotenone-induced 
ROS generation and enhanced the antioxidant system 
through autophagy modulation. The MMP collapse was 
ameliorated by SIRT3 through autopahgy mediation. 
These results suggested that the protective effect of SIRT3 
on mitochondria was via the activation of autophagy.  
        How does SIRT3 improve autophagy levels? Studies 
were carried out to understand the mechanism of the 
ability of SIRT3 to activate autophagic flux. The 
SIRT1/SIRT3-FOXO3a pathway is activated by 
Liraglutide to promote autophagy in non-alcohol fatty 
liver disease [22]. SIRT3 could activate the LKB1-AMPK 
pathway in a  cardiac hypertrophic mouse model[23]. 
AMPK acts on a downstream target, the mammalian 
target of rapamycin (mTOR) kinase, to positively regulate 
autophagy[45]. Several upstream kinases, including liver 
kinase B1 (LKB1, which is activated by energy depletion), 
can activate AMPK by phosphorylation [46]. In this study, 
we found that in the SH-SY5Y cell line, SIRT3 
overexpression could induce the LKB1-AMPK-mTOR 
pathway, which may be part of the mechanism by which 
SIRT3 promotes autophagy. However, more evidence 
regarding SIRT3 and these kinases in a rotenone-induced 
injury model is needed. In addition, we also observed a 
decrease in LKB1 phosphorylation after Dorsomorphin 
treatment. The interaction of AMPK and LKB1 may be 
one possible explanation. Another reason for this may be 
the nonspecific effect of Dorsomorphin, which could also 
inhibit a number of other protein kinases [47]. Two of 
these protein kinases, Lck [48] and Yes [49], have been 
reported to be functionally important for LKB1 
phosphorylation. Lastly, we cannot rule out that there is 
other mechanism for the neuronal protective effect of 
SIRT3 on rotenone-induced damage. 
        We previously reported the protective effect of 
SIRT3 on a Parkinson’s Disease cell model [17]. This 
paper focuses on the mechanism of the protective effect. 
Innovations of our study are: (1) although several in vivo 
and in vitro reports have reported the positive regulation 
of SIRT3 on autophagy [21, 50, 51], it is not clear whether 
there is link between the protective effect of SIRT3 on PD. 
We found in this study that SIRT3 exerts a protective 
effect on a rotenone-induced PD cell model by enhancing 
autophagy; (2) Behrends et al. suggested that AMPK 
might act as an activator to promote autophagy via mTOR 
or through an interaction with ULK1[24]. However, 
studies supporting this theory remain to be conducted. Our 
study demonstrated for the first time that SIRT3 enhances 
autophagy through the LKB1-AMPK-mTOR pathway.  
        Our study provides new data for a better 
understanding of the protective role played by SIRT3 in a 
rotenone-induced PD cell model. To the best of our 
knowledge, this is the first report describing a 
neuroprotective role of SIRT3 on a PD cell model through 
autophagy induction and its related mechanism. However, 
some limitations to this study should be noted: (1) we used 
an in vitro model of PD induced by rotenone in human 
dopaminergic SH-SY5Y cells. Although rotenone as an 
inhibitor of mitochondrial complex I, can induce neuronal 
dysfunction and neurodegeneration, which mimics the 
pathology of PD, there may be different micro-
environments and various other factors that could limit the 
reliability of in vitro study when compared with in vivo 
study or clinical trials. It is our goal to perform in vivo 
experiments for the next step based on the in vitro 
discovery. (2) We used 3-MA to inhibit autophagy to 
verify its protective effect. Although we used LC3 and 
Beclin1 to identify the inhibition, the dual role of 3-MA 
in modulating autophagy is still a concern. Knockdown of 
ATG protein is a more direct way to inhibit autophagy, 
which is a more preferable method in future studies.  
 
Conclusion 
 
In summary, this study demonstrates that SIRT3 induces 
autophagy to ameliorate rotenone-induced SH-SY5Y cell 
damage, inhibit intracellular α-synuclein accumulation, 
increase antioxidants of SOD and GSH, prevent ROS 
generation and ameliorate MMP reduction. The 
mechanism of this autophagy modulation may be via the 
LKB1-AMPK-mTOR pathway. Our findings pose that 
SIRT3 may be a promising drug target for PD treatment. 
Further research regarding the molecular mechanism of 
SIRT3 action and which stage of autophagy is modulated 
by SIRT3 would be required to understand whether 
autophagy serves as a bridge between SIRT3 and PD. 
These efforts will not only provide us with a deeper 
understanding of PD but also may lead to a new means for 
therapeutic intervention in neurodegenerative diseases. 
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